69ɫ��Ƭ

Curious about the effects of recreational cannabis use on the human body? 69ɫ��Ƭ South Africa produced a quick reference guide for insurers.  Read More

Can machines learn? 69ɫ��Ƭ Senior Data Scientist Dr. Dihui Lai thinks so, and he should know. Lai unveiled an 69ɫ��Ƭ-developed “AI-Augmented” underwriting system at the 

Read More

A high-level overview of key life insurance impacts from the legalisation of cannabis in South Africa. 

Read More

69ɫ��Ƭ surveyed 21 group insurers on open enrollment trends involving eight voluntary products. The findings were intriguing. Read More

69ɫ��Ƭ shares basic steps insurers can take to prevent overfitting for more accurate predictive models.  Read More

69ɫ��Ƭ is a global leader in life and health underwriting, honored repeatedly for medical underwriting, underwriting support, underwriting innovation, and training. Read More

When evaluating the value of disability insurance, is it time to consider more than the product and the price? 69ɫ��Ƭ's Neil Parkin explores the importance of case management. Contact us to discuss other case management services. Read More

Expect the unexpected when it comes to the Middle East credit life market -- that is the conclusion of 69ɫ��Ƭ's Tamer Saher in an article in the  EMEA Quarterly Newsletter Read More

Is there a better way to brainstorm? 69ɫ��Ƭ introduces the idea of "life design sprints" in the EMEA Quarterly Newsletter. Read More

As insurers develop accelerated underwriting programs and take steps toward more efficient processes, lower costs, and a streamlined customer experience, innovations across the insurance industry are helping to improve ri...

Read More

For insurers to effectively utilize wearable technology, it is important to understand the metrics captured by devices. Insurers must also be mindful of regulations, set reasonable expectations, and balance the risk and rewards of new developments. This white paper summ... Read More

Hilary Henly, Head of Underwriting, Ireland and Director, Divisional Underwriting Research, presents an innovative review of some non-traditional predictors of mortality and morbidity. She discusses the impact of loneliness, social engagement, and social activity. Gi...

Read More

Richard Russell, Ph.D., Lead Health Data Scientist, U.K., Division of Global Research and Data Analytics (GRDA), addresses polygenic risk scores (PRSs) and provides an update on the quickly advancing knowledge in this area of genetics research and risk assessment. Read More

Across the globe, we've given up the tractor for the subway, the open sky for the concrete jungle. We are now an urban planet. What are the consequences of this urban growth to human health and wellness? Georgiana Pascutiu, M.D., 69ɫ��Ƭ Medical Director, Global Medical Sup... Read More

A brush with death prompts a new appreciation for life ... and life insurance. 
Contact 69ɫ��Ƭ to learn more about insurance careers, our culture, and our mission. 
Read More

Stem cell therapies are becoming increasingly visible and supported in clinical medicine. The U.S. and Canada currently have well-defined stem cell business models and are making significant investments in the field. Japan has also seen new regulations governing regener... Read More

Explore polygenic risk scores, social engagement and other non-traditional predictors of mortality and morbidity.
Read More

Our deepening understanding of physical costs of violence and abuse has profound implications for life and health insurance. 69ɫ��Ƭ’s ROSEBUD^® Consulting Group recently invited Pamela DeWitt-Meza to present a webinar on “Intersections of Abuse” to help... Read More

In this first in a series of four webcasts, Peter Banthorpe, Global Head of Research and Data Analytics at 69ɫ��Ƭ, discusses the growth in direct-to-consumer (DTC) genetic testing, regulatory policies to control genetic discrimination around the world, and potential for...

Read More

During the past decade, significant progression in genetics research has allowed scientists and clinicians to explore the human genome in incredible detail. When coupled with the ever-decreasing cost of DNA sequencing, the era of genomic medicine can now be considered t... Read More